ARAV

Aravive Inc (ARAV)

US
$ 0.0485-7.09%

Price Chart

Key Statistics

Market Cap
$ 2.95M
P/E Ratio
0.00
Revenue (TTM)
$ 6.99M
Volume
3.52M
52W High
$ 0.00
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
2.19

Technicals

50-Day MA
0.1017
200-Day MA
0.5912
52 Week High
N/A
52 Week Low
N/A

About ARAV

Aravive, Inc., a clinical-stage biopharmaceutical company, develops transformative treatments for life-threatening diseases, including cancer and fibrosis in the United States.

Employees
23
Headquarters
Houston, TX
CEO
Dr. Fredric N. Eshelman Pharm.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg